Literature DB >> 23072245

Listeria monocytogenes infection in Crohn's disease treated with adalimumab.

Kaspar J Willson1, Antony Jacob, Mohit P Shetti, Rajesh Bhatia, Kwang Yee, William Osler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23072245     DOI： 10.5694/mja11.10521

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  3 in total

Review 1.  Listeria meningitis complicating a patient with ulcerative colitis on concomitant infliximab and hydrocortisone.

Authors:  V Parihar; S Maguire; A Shahin; Z Ahmed; M O'Sullivan; M Kennedy; C Smyth; R Farrell
Journal:  Ir J Med Sci       Date:  2015-09-10       Impact factor: 1.568

2.  Listeriosis in a Metropolitan Hospital: Is Targeted Therapy a Risk Factor for Infection?

Authors:  Fanfan Xing; Simon K F Lo; Susanna K P Lau; Patrick C Y Woo
Journal:  Front Med (Lausanne)       Date:  2022-04-29

3.  Inducible CYP2J2 and its product 11,12-EET promotes bacterial phagocytosis: a role for CYP2J2 deficiency in the pathogenesis of Crohn's disease?

Authors:  Jonas Bystrom; Scott J Thomson; Jörgen Johansson; Matthew L Edin; Darryl C Zeldin; Derek W Gilroy; Andrew M Smith; David Bishop-Bailey
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.